Radek Indra1, Michaela Moserova2, Miroslav Sulc2, Eva Frei3, Marie Stiborova1. 1. Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic. stiborov@natur.cuni.cz. 2. Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic. 3. Division of Preventive Oncology, National Center for Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abstract
OBJECTIVES: Cytochrome P450 (CYP) 1A1 is the most important enzyme in both activation and detoxification of carcinogenic benzo[a]pyrene (BaP), in combination with microsomal epoxide hydrolase (mEH). To evaluate metabolism of BaP in human, identification of a suitable animal model that mimics the metabolic fate of BaP in human is of great importance. The aim of this work was to compare BaP oxidation by human CYP1A1 and CYP1A1 of one animal model, rat. Investigation of the effect of cytochrome b5 on BaP oxidation by CYP1A1 was another target of this study. METHODS: High performance liquid chromatography (HPLC) was employed for separation of BaP metabolites formed by enzymatic systems. Their structures were identified by mass- and NMR-spectrometry. RESULTS: Human hepatic microsomes oxidized BaP to BaP-9,10-dihydrodiol, BaP-4,5-dihydrodiol, BaP-7,8-dihydrodiol, BaP-1,6-dione, BaP-3,6-dione and BaP-3-ol. The same metabolites were generated by rat liver microsomes, but BaP-9-ol and a metabolite Mx, the structure of which has not been identified as yet, were also formed in these microsomes. Human CYP1A1 expressed with NADPH:CYP reductase (POR) in Supersomes™ oxidized BaP to the same metabolites as microsomes, but BaP-4,5-dihydrodiol has not been detected. Rat recombinant CYP1A1 in this SupersomesTM system oxidized BaP to BaP-9,10-dihydrodiol, a metabolite Mx, BaP-4,5-dihydrodiol, BaP-7,8-dihydrodiol, BaP-1,6-dione, BaP-3,6-dione, BaP-9-ol and BaP-3-ol. Addition of cytochrome b5 to rat and human recombinant CYP1A1 systems led to a more than 2-fold increase in BaP oxidation. CONCLUSION: The results show similarities between human and rat CYP1A1 in BaP oxidation and demonstrate rats as a suitable model mimicking BaP oxidation in human.
OBJECTIVES:Cytochrome P450 (CYP) 1A1 is the most important enzyme in both activation and detoxification of carcinogenicbenzo[a]pyrene (BaP), in combination with microsomal epoxide hydrolase (mEH). To evaluate metabolism of BaP in human, identification of a suitable animal model that mimics the metabolic fate of BaP in human is of great importance. The aim of this work was to compare BaP oxidation by humanCYP1A1 and CYP1A1 of one animal model, rat. Investigation of the effect of cytochrome b5 on BaP oxidation by CYP1A1 was another target of this study. METHODS: High performance liquid chromatography (HPLC) was employed for separation of BaP metabolites formed by enzymatic systems. Their structures were identified by mass- and NMR-spectrometry. RESULTS:Human hepatic microsomes oxidized BaP to BaP-9,10-dihydrodiol, BaP-4,5-dihydrodiol, BaP-7,8-dihydrodiol, BaP-1,6-dione, BaP-3,6-dione and BaP-3-ol. The same metabolites were generated by rat liver microsomes, but BaP-9-ol and a metabolite Mx, the structure of which has not been identified as yet, were also formed in these microsomes. HumanCYP1A1 expressed with NADPH:CYP reductase (POR) in Supersomes™ oxidized BaP to the same metabolites as microsomes, but BaP-4,5-dihydrodiol has not been detected. Rat recombinant CYP1A1 in this SupersomesTM system oxidized BaP to BaP-9,10-dihydrodiol, a metabolite Mx, BaP-4,5-dihydrodiol, BaP-7,8-dihydrodiol, BaP-1,6-dione, BaP-3,6-dione, BaP-9-ol and BaP-3-ol. Addition of cytochrome b5 to rat and human recombinant CYP1A1 systems led to a more than 2-fold increase in BaP oxidation. CONCLUSION: The results show similarities between human and ratCYP1A1 in BaP oxidation and demonstrate rats as a suitable model mimicking BaP oxidation in human.
Authors: Evgenii A Konorov; Mikhail A Nikitin; Kirill V Mikhailov; Sergey N Lysenkov; Mikhail Belenky; Peter L Chang; Sergey V Nuzhdin; Victoria A Scobeyeva Journal: BMC Evol Biol Date: 2017-02-07 Impact factor: 3.260
Authors: Aline Cristina Ferreira Rodrigues; Tatiana de Oliveira Moneró; Rosa Toyoko Shiraishi Frighetto; Eduardo Alves de Almeida Journal: Environ Sci Pollut Res Int Date: 2014-10-05 Impact factor: 4.223
Authors: Marie Stiborová; Radek Indra; Michaela Moserová; Eva Frei; Heinz H Schmeiser; Klaus Kopka; David H Phillips; Volker M Arlt Journal: Chem Res Toxicol Date: 2016-07-20 Impact factor: 3.739
Authors: Marie Stiborová; František Bárta; Kateřina Levová; Petr Hodek; Heinz H Schmeiser; Volker M Arlt; Václav Martínek Journal: Int J Mol Sci Date: 2015-11-18 Impact factor: 5.923
Authors: Marie Stiborová; Michaela Moserová; Iveta Mrízová; Helena Dračínská; Václav Martínek; Radek Indra; Eva Frei; Vojtěch Adam; René Kizek; Heinz H Schmeiser; Kateřina Kubáčková; Volker M Arlt Journal: Monatsh Chem Date: 2016-01-12 Impact factor: 1.451
Authors: Marie Stiborová; Radek Indra; Michaela Moserová; Miroslav Šulc; Petr Hodek; Eva Frei; Heinz H Schmeiser; Volker M Arlt Journal: Monatsh Chem Date: 2016-03-09 Impact factor: 1.451
Authors: Marie Stiborová; Radek Indra; Michaela Moserová; Lucie Bořek-Dohalská; Petr Hodek; Eva Frei; Klaus Kopka; Heinz H Schmeiser; Volker M Arlt Journal: Monatsh Chem Date: 2017-07-10 Impact factor: 1.451